During the past decade, Clinical Research Puerto Rico conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 45 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 23 clinical trials were completed. i.e. 88.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Puerto Rico" #1 sponsor was "Gilead Sciences" with 28 trials, followed by "Eli Lilly and Company" with 22 trials sponsored, "TaiMed Biologics Inc." with 5 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "Agouron Pharmaceuticals" with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Puerto Rico" #1 collaborator was "Westat" with 2 trials as a collaborator, "ACM Pivotal Global Central Laboratory" with 1 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Puerto Rico" are "HIV Infections" (22 trials), "HIV" (9 trials), "HIV-1 Infection" (7 trials), "Acquired Immunodeficiency Syndrome" (5 trials) and "HIV-1-infection" (4 trials). Many other conditions were trialed in "Clinical Research Puerto Rico" in a lesser frequency.

Most popular intervention types in "Clinical Research Puerto Rico" are "Drug" (76 trials), "Biological" (8 trials), "Device" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "FTC/TDF" (6 trials), "COBI" (5 trials), "Tirzepatide" (5 trials) and "ATV" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Puerto Rico" are 83 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Puerto Rico". 1 are not yet recruiting, 5 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Clinical Research Puerto Rico, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Puerto Rico, 7 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".